Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Lung Tuberculosis
100%
Prognostic Factor
74%
Lung
73%
Computer Assisted Tomography
71%
Hazard Ratio
50%
Non Small Cell Lung Cancer
49%
Lung Cancer
49%
Odds Ratio
42%
Artificial Respiration
36%
Lung Adenocarcinoma
33%
Clinical Feature
32%
Idiopathic Interstitial Pneumonia
28%
Stenosis
24%
Acute Respiratory Distress Syndrome
24%
Asthma
23%
Atypical Mycobacterium
23%
Retrospective Cohort Study
21%
Chronic Obstructive Pulmonary Disease
21%
Stenting
20%
Pulmonary Embolism
20%
Lung Nodule
20%
Primary Tumor
20%
Elderly Patient
19%
Dyspnea
19%
Body Mass Index
19%
Epidermal Growth Factor Receptor
18%
Influenza A (H1N1)
18%
Tuberculosis Treatment
18%
Levofloxacin
18%
Multidrug Resistant Tuberculosis
18%
Sputum
18%
Patient Referral
17%
Lung Biopsy
17%
Thorax Radiography
17%
Bronchial Artery
16%
Medical Record
16%
Forced Expiratory Volume
15%
Biopsy Technique
15%
Low Drug Dose
14%
Bronchoscopy
14%
Arterial Embolization
14%
Transthoracic Biopsy
14%
Polyethylene Terephthalate
14%
Hospital Mortality
14%
Sputum Culture
13%
Pathogen
13%
Lymphocyte
13%
Proportional Hazards Model
13%
Idiopathic Pulmonary Fibrosis
13%
Lung Lesion
13%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tuberculosis
71%
Non Small Cell Lung Cancer
43%
Clinical Feature
33%
Asthma
33%
Acute Respiratory Failure
33%
Lung Cancer
32%
Chronic Obstructive Lung Disease
30%
Lung Adenocarcinoma
28%
Gefitinib
25%
Erlotinib
25%
Epidermal Growth Factor Receptor
21%
Prevalence
19%
Epidermal Growth Factor Receptor Kinase Inhibitor
19%
Community Acquired Pneumonia
18%
Levofloxacin
18%
Hemoptysis
17%
Hospital Mortality
14%
Interleukin 2
14%
Atypical Mycobacterium
12%
Coughing
12%
Tuberculostatic Agent
11%
Influenza A (H1N1)
10%
Cohort Study
10%
Pleura Effusion
9%
Syndrome
9%
Atelectasis
9%
Overall Survival
9%
Allergic Reaction
9%
Reflux Esophagitis
9%
Influenza A Virus (H1N1)
9%
Toll Like Receptor 2
9%
Prospective Study
9%
Observational Study
9%
Paclitaxel
9%
Small Cell Lung Cancer
9%
Fibrosing Alveolitis
9%
CYP2E1
9%
Spontaneous Pneumothorax
9%
Loeffler Pneumonia
9%
Femur Fracture
9%
Chest Infection
9%
Adult Respiratory Distress Syndrome
9%
Cytokine
9%
Hepatotoxicity
9%
Cidofovir
9%
Neopterin
9%
Lymphocytopenia
9%
Topotecan
9%
Methacholine
9%
Moxifloxacin
9%
Nursing and Health Professions
Confidence Interval
51%
Odds Ratio
25%
Obstructive Lung Disease
23%
Non Small Cell Lung Cancer
23%
Hazard Ratio
22%
Body Mass
19%
Lung Cancer
18%
Artificial Respiration
18%
Elderly Patient
15%
Tertiary Care Center
12%
Forced Expiratory Volume
10%
Clinical Outcome
10%
Clinical Feature
10%
Pandemic Influenza
9%
Tidal Volume
9%
Long Term Care
9%
Grip Strength
9%
Fibrosing Alveolitis
9%
Adult Respiratory Distress Syndrome
9%
Prevalence
9%
Influenza A (H1N1)
9%
Femur Fracture
9%
Systolic Blood Pressure
9%
Acute Cholecystitis
9%
Community Acquired Pneumonia
9%
Hospital Mortality
7%
Proportional Hazards Model
7%
Intensive Care
5%
Asthma
5%